Video
29 Jul 2022

Meet our experts - abuse deterrent drug product formulations

Dr. Daniel Kirschner, Sr. Director, Analytical Development at Cambrex discusses abuse deterrent drug product formulations - quantifying the drug, excipient & degradants in abuse liability studies

Content provided by our supplier

Cambrex

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company

Other Content from Cambrex (31)